Trial Profile
Phase III study of pembrolizumab in patients with gastroesophageal adenocarcinoma
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 20 Aug 2015
Price :
$35
*
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Adenocarcinoma
- Focus Therapeutic Use
- 20 Aug 2015 New trial record